Women with breast cancer are more likely to discontinue chemoprevention therapy if menopause-specific symptoms negatively impact their quality of life (QOL), according to a study published in the Journal of Clinical...
Women with breast cancer are more likely to discontinue chemoprevention therapy if menopause-specific symptoms negatively impact their quality of life (QOL), according to a study published in the Journal of Clinical...
Women...